Preclinical assessment of checkpoint blockade combined with DNA methyltransferase inhibition in high-risk pediatric brain tumors reveals limited therapeutic synergyDeepak Mishra, Rachid Drissi, Dean Popovski et al.|Neuro-Oncology Advances|2025Cited by 5